Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Add-on aliskiren in chronic heart failure with renal dysfunction
2008-007881-45Phase 2Active
- Sponsor
- University Medical Center Groningen
- Start
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in chronic heart failure (CHF) and chronic kidney disease (CKD) comparing Aliskiren add-on with Placebo add-on (2 arms). Primary endpoint: Change in renal blood flow. Started Dec 2008; status: active.
02
Drugs
aliskiren
03
Conditions
chronic heart failure (CHF)chronic kidney disease (CKD)
Beyond the preview
Go deeper on 2008-007881-45.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-007881-45.